Cargando…

Resistome and virulome of high-risk pandemic clones of multidrug-resistant extra-intestinal pathogenic Escherichia coli (ExPEC) isolated from tertiary healthcare settings in Uganda

Multi-drug resistant (MDR) globally disseminated extraintestinal pathogenic high-risk Escherichia coli (ExPEC) clones are threatening the gains in bacterial disease management. In this study, we evaluated the genomic structure including the resistome and virulome of the E. coli isolates from extrain...

Descripción completa

Detalles Bibliográficos
Autores principales: Byarugaba, Denis K., Erima, Bernard, Wokorach, Godfrey, Alafi, Stephen, Kibuuka, Hannah, Mworozi, Edison, Musinguzi, Ambrose K., Kiyengo, James, Najjuka, Florence, Wabwire-Mangen, Fred
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664879/
https://www.ncbi.nlm.nih.gov/pubmed/37992119
http://dx.doi.org/10.1371/journal.pone.0294424
_version_ 1785148803027828736
author Byarugaba, Denis K.
Erima, Bernard
Wokorach, Godfrey
Alafi, Stephen
Kibuuka, Hannah
Mworozi, Edison
Musinguzi, Ambrose K.
Kiyengo, James
Najjuka, Florence
Wabwire-Mangen, Fred
author_facet Byarugaba, Denis K.
Erima, Bernard
Wokorach, Godfrey
Alafi, Stephen
Kibuuka, Hannah
Mworozi, Edison
Musinguzi, Ambrose K.
Kiyengo, James
Najjuka, Florence
Wabwire-Mangen, Fred
author_sort Byarugaba, Denis K.
collection PubMed
description Multi-drug resistant (MDR) globally disseminated extraintestinal pathogenic high-risk Escherichia coli (ExPEC) clones are threatening the gains in bacterial disease management. In this study, we evaluated the genomic structure including the resistome and virulome of the E. coli isolates from extraintestinal infections using whole genome sequencing (WGS). The results highlight that isolates were highly resistant (≥ 90.0%) to commonly used antibiotics (Ampicillin, Trimethoprim-Sulfamethoxazole, Nalidixic acid, and Piperacillin) and were less (<14%) resistant to last resort antibiotics; Imipenem (10.94%) and Meropenem (10.20%). A greater proportion of the E. coli isolates belonged to phylogroup B2 (30.52%) and phylogroup A (27.37%). The sequence types ST131 of phylogroup B2 (21.05%) and ST648 of phylogroup F (9.3%) were the dominant pandemic high-risk clones identified in addition to the ST1193, ST410, ST69, ST38, ST405, and ST10. Many of the isolates were MDR and most (64.58%) carried the blaCTX-M-15 gene for extended-spectrum β-lactamases. There was a high correlation between phylogroups and the occurrence of both antimicrobial resistance and virulence genes. The cephalosporin-resistance gene blaEC-5 was only found in phylogroup B2 while blaEC-8 and blaEC-19, were only found within phylogroup D and phylogroup F respectively. Aminoglycoside gene (aadA1) was only associated with phylogroups D and C. The isolates were armed with a broad range of virulence genes including adhesins, toxins, secreted proteases, iron uptake genes, and others. The yfcv, chuA, and kpsE genes preferentially occurred among isolates of phylogroup B2. The study underlines the predominance of MDR internationally disseminated high-risk ExPEC clones with a broad range of virulence genes known to be highly transmissible in healthcare and community settings.
format Online
Article
Text
id pubmed-10664879
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-106648792023-11-22 Resistome and virulome of high-risk pandemic clones of multidrug-resistant extra-intestinal pathogenic Escherichia coli (ExPEC) isolated from tertiary healthcare settings in Uganda Byarugaba, Denis K. Erima, Bernard Wokorach, Godfrey Alafi, Stephen Kibuuka, Hannah Mworozi, Edison Musinguzi, Ambrose K. Kiyengo, James Najjuka, Florence Wabwire-Mangen, Fred PLoS One Research Article Multi-drug resistant (MDR) globally disseminated extraintestinal pathogenic high-risk Escherichia coli (ExPEC) clones are threatening the gains in bacterial disease management. In this study, we evaluated the genomic structure including the resistome and virulome of the E. coli isolates from extraintestinal infections using whole genome sequencing (WGS). The results highlight that isolates were highly resistant (≥ 90.0%) to commonly used antibiotics (Ampicillin, Trimethoprim-Sulfamethoxazole, Nalidixic acid, and Piperacillin) and were less (<14%) resistant to last resort antibiotics; Imipenem (10.94%) and Meropenem (10.20%). A greater proportion of the E. coli isolates belonged to phylogroup B2 (30.52%) and phylogroup A (27.37%). The sequence types ST131 of phylogroup B2 (21.05%) and ST648 of phylogroup F (9.3%) were the dominant pandemic high-risk clones identified in addition to the ST1193, ST410, ST69, ST38, ST405, and ST10. Many of the isolates were MDR and most (64.58%) carried the blaCTX-M-15 gene for extended-spectrum β-lactamases. There was a high correlation between phylogroups and the occurrence of both antimicrobial resistance and virulence genes. The cephalosporin-resistance gene blaEC-5 was only found in phylogroup B2 while blaEC-8 and blaEC-19, were only found within phylogroup D and phylogroup F respectively. Aminoglycoside gene (aadA1) was only associated with phylogroups D and C. The isolates were armed with a broad range of virulence genes including adhesins, toxins, secreted proteases, iron uptake genes, and others. The yfcv, chuA, and kpsE genes preferentially occurred among isolates of phylogroup B2. The study underlines the predominance of MDR internationally disseminated high-risk ExPEC clones with a broad range of virulence genes known to be highly transmissible in healthcare and community settings. Public Library of Science 2023-11-22 /pmc/articles/PMC10664879/ /pubmed/37992119 http://dx.doi.org/10.1371/journal.pone.0294424 Text en © 2023 Byarugaba et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Byarugaba, Denis K.
Erima, Bernard
Wokorach, Godfrey
Alafi, Stephen
Kibuuka, Hannah
Mworozi, Edison
Musinguzi, Ambrose K.
Kiyengo, James
Najjuka, Florence
Wabwire-Mangen, Fred
Resistome and virulome of high-risk pandemic clones of multidrug-resistant extra-intestinal pathogenic Escherichia coli (ExPEC) isolated from tertiary healthcare settings in Uganda
title Resistome and virulome of high-risk pandemic clones of multidrug-resistant extra-intestinal pathogenic Escherichia coli (ExPEC) isolated from tertiary healthcare settings in Uganda
title_full Resistome and virulome of high-risk pandemic clones of multidrug-resistant extra-intestinal pathogenic Escherichia coli (ExPEC) isolated from tertiary healthcare settings in Uganda
title_fullStr Resistome and virulome of high-risk pandemic clones of multidrug-resistant extra-intestinal pathogenic Escherichia coli (ExPEC) isolated from tertiary healthcare settings in Uganda
title_full_unstemmed Resistome and virulome of high-risk pandemic clones of multidrug-resistant extra-intestinal pathogenic Escherichia coli (ExPEC) isolated from tertiary healthcare settings in Uganda
title_short Resistome and virulome of high-risk pandemic clones of multidrug-resistant extra-intestinal pathogenic Escherichia coli (ExPEC) isolated from tertiary healthcare settings in Uganda
title_sort resistome and virulome of high-risk pandemic clones of multidrug-resistant extra-intestinal pathogenic escherichia coli (expec) isolated from tertiary healthcare settings in uganda
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664879/
https://www.ncbi.nlm.nih.gov/pubmed/37992119
http://dx.doi.org/10.1371/journal.pone.0294424
work_keys_str_mv AT byarugabadenisk resistomeandvirulomeofhighriskpandemicclonesofmultidrugresistantextraintestinalpathogenicescherichiacoliexpecisolatedfromtertiaryhealthcaresettingsinuganda
AT erimabernard resistomeandvirulomeofhighriskpandemicclonesofmultidrugresistantextraintestinalpathogenicescherichiacoliexpecisolatedfromtertiaryhealthcaresettingsinuganda
AT wokorachgodfrey resistomeandvirulomeofhighriskpandemicclonesofmultidrugresistantextraintestinalpathogenicescherichiacoliexpecisolatedfromtertiaryhealthcaresettingsinuganda
AT alafistephen resistomeandvirulomeofhighriskpandemicclonesofmultidrugresistantextraintestinalpathogenicescherichiacoliexpecisolatedfromtertiaryhealthcaresettingsinuganda
AT kibuukahannah resistomeandvirulomeofhighriskpandemicclonesofmultidrugresistantextraintestinalpathogenicescherichiacoliexpecisolatedfromtertiaryhealthcaresettingsinuganda
AT mworoziedison resistomeandvirulomeofhighriskpandemicclonesofmultidrugresistantextraintestinalpathogenicescherichiacoliexpecisolatedfromtertiaryhealthcaresettingsinuganda
AT musinguziambrosek resistomeandvirulomeofhighriskpandemicclonesofmultidrugresistantextraintestinalpathogenicescherichiacoliexpecisolatedfromtertiaryhealthcaresettingsinuganda
AT kiyengojames resistomeandvirulomeofhighriskpandemicclonesofmultidrugresistantextraintestinalpathogenicescherichiacoliexpecisolatedfromtertiaryhealthcaresettingsinuganda
AT najjukaflorence resistomeandvirulomeofhighriskpandemicclonesofmultidrugresistantextraintestinalpathogenicescherichiacoliexpecisolatedfromtertiaryhealthcaresettingsinuganda
AT wabwiremangenfred resistomeandvirulomeofhighriskpandemicclonesofmultidrugresistantextraintestinalpathogenicescherichiacoliexpecisolatedfromtertiaryhealthcaresettingsinuganda